1019 US Highway 202-206, Building K
NJ Center of Excellence
Nevakar is a specialty pharmaceutical company, focused on developing innovative products in injectable and ophthalmic space.
Our goal is to develop enhanced products that address unmet clinical and/or commercial needs of currently [FDA] approved molecules, through intensive R&D and clinical efforts.
These drug repositioning efforts are focused on:
1. Developing novel or improved formulation
2. Designing an improved and functional packaging
3. Novel drug delivery approaches
4. Regulatory and clinical strategies
Resulting new and repositioned products are expected to provide patient centric benefits, while ensuring incremental value proposition for the healthcare system.
These new products with proprietary enhancements are filed with FDA, primarily under 505(b)(2) regulatory pathway.
Nevakar’s business model is supported by state of the art R&D infrastructure, located in
NJ Center of Excellence, and a well experienced management and leadership team.
CEO: Navneet Puri, PhD
COO: Sriram Ramanathan, MS, MBA